Literature DB >> 15509552

Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts.

Milene Russelakis-Carneiro1, Claudio Hetz, Kinsey Maundrell, Claudio Soto.   

Abstract

The main event in the pathogenesis of prion diseases is the conversion of the cellular prion protein (PrP(C)) into the abnormal, protease-resistant prion protein (PrP(res)). PrP(C) is a GPI-anchored protein located in lipid rafts or detergent-resistant membranes (DRMs). Here we describe the association of PrP with DRMs in neuronal cell bodies and axons during the course of murine scrapie and its relation with the distribution of the PrP-interacting proteins caveolin 1 and synaptophysin. Scrapie infection triggered the accumulation of PrP(res) in DRMs from retinas and optic nerves from early stages of the disease before evidence of neuronal cell loss. Most of the PrP(res) remained associated with lipid rafts throughout different stages in disease progression. In contrast to PrP(res), caveolin 1 and synaptophysin in retina and optic nerves shifted to non-DRM fractions during the course of scrapie infection. The accumulation of PrP(res) in DRMs was not associated with a general alteration in their composition, because no change in the total protein distribution across the sucrose gradient or in the flotation characteristics of the glycosphingolipid GM1 or Thy-1 were observed until advanced stages of the disease. However, an increase in total cholesterol levels was observed in optic nerve and retinas. Only during late stages of the disease was a decrease in the number of neuronal cell bodies observed, suggesting that synaptic abnormalities are the earliest sign of neuronal dysfunction that ultimately results in neuronal death. These results indicate that prion replication triggers an abnormal localization of caveolin 1 and synaptophysin, which in turn may alter neuronal function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509552      PMCID: PMC1618653          DOI: 10.1016/S0002-9440(10)63439-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

Review 1.  Protein misfolding and disease: the case of prion disorders.

Authors:  C Hetz; C Soto
Journal:  Cell Mol Life Sci       Date:  2003-01       Impact factor: 9.261

2.  Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.

Authors:  Clive Bate; Mario Salmona; Luisa Diomede; Alun Williams
Journal:  J Biol Chem       Date:  2004-01-29       Impact factor: 5.157

Review 3.  Cholesterol, lipid rafts, and disease.

Authors:  Kai Simons; Robert Ehehalt
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

4.  The membrane domains occupied by glycosylphosphatidylinositol-anchored prion protein and Thy-1 differ in lipid composition.

Authors:  Britta Brügger; Catriona Graham; Iris Leibrecht; Enrico Mombelli; Angela Jen; Felix Wieland; Roger Morris
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

5.  Changes in the glycosylation pattern of prion protein in murine scrapie. Implications for the mechanism of neurodegeneration in prion diseases.

Authors:  Milene Russelakis-Carneiro; Gabriela P Saborio; Laurence Anderes; Claudio Soto
Journal:  J Biol Chem       Date:  2002-07-18       Impact factor: 5.157

6.  Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease.

Authors:  C Cunningham; R Deacon; H Wells; D Boche; S Waters; C Picanco Diniz; H Scott; J N P Rawlins; V H Perry
Journal:  Eur J Neurosci       Date:  2003-05       Impact factor: 3.386

Review 7.  Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease.

Authors:  I Ferrer
Journal:  Cerebellum       Date:  2002-07       Impact factor: 3.847

8.  Immunoseparation of Prion protein-enriched domains from other detergent-resistant membrane fractions, isolated from neuronal cells.

Authors:  Laura Botto; Massimo Masserini; Arianna Cassetti; Paola Palestini
Journal:  FEBS Lett       Date:  2004-01-16       Impact factor: 4.124

9.  Is loss of function of the prion protein the cause of prion disorders?

Authors:  Claudio Hetz; Kinsey Maundrell; Claudio Soto
Journal:  Trends Mol Med       Date:  2003-06       Impact factor: 11.951

10.  Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein.

Authors:  Claudio Hetz; Milene Russelakis-Carneiro; Kinsey Maundrell; Joaquin Castilla; Claudio Soto
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

View more
  21 in total

1.  Reversibility of prion-induced neurodegeneration.

Authors:  Claudio Soto
Journal:  Lancet Neurol       Date:  2007-04       Impact factor: 44.182

2.  Do prion protein gene polymorphisms induce apoptosis in non-mammals?

Authors:  Tuğçe Birkan; Mesut Şahin; Zubeyde Öztel; Erdal Balcan
Journal:  J Biosci       Date:  2016-03       Impact factor: 1.826

3.  Mitochondrial Respiration Is Impaired during Late-Stage Hamster Prion Infection.

Authors:  Robert Faris; Roger A Moore; Anne Ward; Dan E Sturdevant; Suzette A Priola
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

4.  Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra.

Authors:  Gerald S Baron; Andrew G Hughson; Gregory J Raymond; Danielle K Offerdahl; Kelly A Barton; Lynne D Raymond; David W Dorward; Byron Caughey
Journal:  Biochemistry       Date:  2011-05-03       Impact factor: 3.162

Review 5.  The intricate mechanisms of neurodegeneration in prion diseases.

Authors:  Claudio Soto; Nikunj Satani
Journal:  Trends Mol Med       Date:  2011-01       Impact factor: 11.951

6.  Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines.

Authors:  Alessandra Pani; Claudia Norfo; Claudia Abete; Claudia Mulas; Marirosa Putzolu; Sergio Laconi; Christina Doriana Orrù; M Dolores Cannas; Sarah Vascellari; Paolo La Colla; Sandra Dessì
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

7.  Dendritic pathology in prion disease starts at the synaptic spine.

Authors:  Martin Fuhrmann; Gerda Mitteregger; Hans Kretzschmar; Jochen Herms
Journal:  J Neurosci       Date:  2007-06-06       Impact factor: 6.167

Review 8.  Stressing out the ER: a role of the unfolded protein response in prion-related disorders.

Authors:  Claudio A Hetz; Claudio Soto
Journal:  Curr Mol Med       Date:  2006-02       Impact factor: 2.222

9.  Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth.

Authors:  Naoki Ichikawa; Kazuhisa Iwabuchi; Hidetake Kurihara; Kumiko Ishii; Toshihide Kobayashi; Takako Sasaki; Nobutaka Hattori; Yoshikuni Mizuno; Kentaro Hozumi; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  J Cell Sci       Date:  2009-01-15       Impact factor: 5.285

10.  Chronic N-acetylcysteine treatment alleviates acute lipopolysaccharide-induced working memory deficit through upregulating caveolin-1 and synaptophysin in mice.

Authors:  Xianzhi Shen; Yanyun Sun; Mengwei Wang; Hui Shu; Li-Juan Zhu; Pei-Yun Yan; Jun-Fang Zhang; Xinchun Jin
Journal:  Psychopharmacology (Berl)       Date:  2017-10-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.